Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH

Lignende værker

• Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling
  af: Rashid, Jahidur, et al.
  Udgivet: (2019)
• Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH)
  af: Rashid, Jahidur, et al.
  Udgivet: (2017)
• Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency
  af: Gupta, Nilesh, et al.
  Udgivet: (2017)
• CAR, a Homing Peptide, Prolongs Pulmonary Preferential Vasodilation by Increasing Pulmonary Retention and Reducing Systemic Absorption of Liposomal Fasudil
  af: Keshavarz, Ali, et al.
  Udgivet: (2019)
• Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application
  af: Al-Hilal, Taslim A., et al.
  Udgivet: (2020)